Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin.

Front Pharmacol · 2021 · PMC8397445 · PMID 34456735

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Compared to placebo, any aspirin given to KD patients, such as 3–5, 30–50, and 80–100 mg/kg/day, showed a decreasing trend in the prevalence of IVIG resistance, but its CI overlapped with the null effect of one.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.